Immatics has become the latest partner for GSK in the area of cell therapy for cancer to see its ... and originated by Immunocore, in 2021. GSK's chief scientific officer Tony Wood (pictured ...

Armed with data from a small phase 1/2 bridging study, MeiraGTx is preparing to take its gene therapy for Parkinson's disease into a pivotal trial. Shares in the Anglo-US biotech rose sharply ...

(Charles Knoblock / AP Photo) By signing up, you confirm that you are over the age of 16 and agree to receive occasional promotional offers for programs that support The Nation’s journalism.